Skip to main content
John Ward, MD, Oncology, Salt Lake City, UT

John Ward MD

Breast Cancer, Hematologic Oncology


Professor of Medicine

Join to View Full Profile
  • 1950 Circle of HopeClinic 3aSalt Lake City, UT 84112

  • Phone+1 801-585-0100

  • Fax+1 801-587-8143

Dr. Ward is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Utah Health
    University of Utah HealthFellowship, Hematology and Medical Oncology, 1979 - 1982
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1976 - 1979
  • Duke University Hospital
    Duke University HospitalInternship, Internal Medicine, 1976 - 1977
  • University of Utah School of Medicine
    University of Utah School of MedicineClass of 1976

Certifications & Licensure

  • UT State Medical License
    UT State Medical License 1979 - 2026
  • WY State Medical License
    WY State Medical License 2002 - 2024
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Top MD Consumers Checkbook

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • The Six Least Survivable Cancers – and How to Protect Yourself Against Them
    The Six Least Survivable Cancers – and How to Protect Yourself Against ThemJanuary 15th, 2025

Grant Support

  • Clinical Trial: Study Of Tamoxifen And Raloxifene (STAR) For The Prevention Of BNational Center For Research Resources2008
  • Study Of Tamoxifen And Raloxifene (STAR) For The Prevention Of Breast CancerNational Center For Research Resources2007
  • Study For Prevention Of Breast CancerNational Center For Research Resources2004–2006
  • Chemoprevention Trial (TAMOXIFEN) In Proliferative Breast DiseaseNational Center For Research Resources1997–1999
  • National Surgical Adjuvant Breast And Bowel Project--Breast Cancer PreventionNational Center For Research Resources1997
  • Genetic Analysis Of Breast CancerNational Center For Research Resources1997

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: